CA
Camurus AB
CAMRF · OTC
$61.75 +0.00% (+$0.00)
1M -3.89%
Market Cap 36.1B kr
P/E Ratio 53.37x
Div. Yield -
ROE 15.54%
Bulios Fair Price
$34.22
44.6% downside
Current Price
$61.75
Undervalued Fair Value Overvalued
According to Bulios Fair Price, CAMRF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
5/9Valuation
10 /100
Expensive PEG 0.68x
P/S 15.96x
P/B 7.71x
Growth
100 /100
Growing Rev. growth 33.30%
FCF growth 94.52%
Book val. growth 62.08%
Profitability
100 /100
Strong Net margin 29.91%
Op. margin 36.32%
FCF margin 28.93%
Quality
71 /100
Excellent ROE 15.54%
ROA 12.75%
Asset turnover 0.43x
Debt
100 /100
Low Current ratio 10.01x
Int. coverage 147.07x
Net debt/EBITDA -4.44x
Stability
34 /100
Moderate Rev. volatility 37.75%
EPS volatility 353.81%
Profitable years 4
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about CAMRF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Sven Fredrik Tiberg
Employees
285
Headquarters
Lund
Upcoming events
05 NOV
Earnings
Upcoming earnings report